Measuring Dysphagia After ACDF Surgery Through A Novel Wearable Sensor

Sponsor
Northwestern University (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT04921800
Collaborator
(none)
11
1
1
16.6
0.7

Study Details

Study Description

Brief Summary

The purpose of this study is to assess the function and reliability of a noninvasive, skin-like electronic sensor. The investigators hypothesize that this skin sensor will address an unmet need to wirelessly and noninvasively monitor and characterize the recovery process in post-operative patients who have undergone anterior cervical discectomy and fusion (ACDF). Specifically, the investigators will validate the use of the sensor in this patient population through monitoring of key physiological signals in the recovery process, including heart rate, respiratory rate, swallow count, talking time, energy expenditure, neck specific motion, and body orientation.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Anterior Cervical Discectomy & Fusion
  • Device: Application of ADAM mechanoacoustic skin sensor
N/A

Detailed Description

Dysphagia, dysphonia, and loss of cervical range of motion (ROM) are common complications after anterior cervical spine surgery, specifically anterior cervical discectomy and fusion (ACDF). Despite their clinical importance, studies on the treatment and/or prevention of these complications are limited due to the lack of valid and reliable outcome measures. The majority of research is found in the otolaryngology literature and has focused on disease pathophysiology, diagnosis, and therapy.

Dysphagia and dysphonia are widely measured by patient self-reported questionnaires, including the MD Anderson Dysphasia Inventory and SWAL-QOL. However, these validated outcome tools are cumbersome to complete and, therefore, have not been widely accepted into clinical practice, including in postoperative ACDF patients. The Bazaz score, a subjective questionnaire that has not been validated in the literature, has also been used to evaluate dysphagia after ACDF. Assessment using the Bazaz score is based on clinical examination, with the surgeon listening to the patient's voice and documenting hoarseness in the post-operative period. Recently, new patient-centered outcomes, the Eating Assessment Tool (EAT-10) and Voice Handicap Index (VHI-10) have been developed. Both EAT-10 and VHI-10 have excellent validity and reliability in evaluating dysphagia and dysphonia, respectively, in post-operative ACDF patients and can be used to document the initial dysphagia or dysphonia severity and monitor the treatment response in people with a wide array of swallowing and voice disorders. However, these methods of evaluating dysphagia and dysphonia alone offer limited information about the severity and characteristic of dysphagia or dysphonia and do not provide continuous monitoring of swallowing or speaking function throughout the post-operative period.

The wearable sensors under investigation in this study offer a novel, noninvasive, and easy-to-use way to monitor dysphagia, dysphonia, cervical ROM, and overall recovery progress in post-operative ACDF patients. Previous testing has demonstrated the ability of our sensors to monitor vital signs (including heart rate and respiratory rate), swallow count, talking time, energy expenditure, cervical neck movement, and body orientation. Sensor-measured swallow count and talking time, in conjunction with EAT-10 and VHI-10 scores, can provide a comprehensive view of the progression of dysphagia and dysphonia. Cervical neck movements measured by the sensor can enable continuous assessment of cervical ROM. Other general metrics captured by the sensors, including heart rate, respiratory rate, energy expenditure, and body orientation can provide other meaningful measures of recovery in post-operative ACDF patients. These sensors have also received positive feedback from patients and physicians on their comfort, ease of use, and application, further demonstrating the potential value of these sensors in improving the quality of post-operative care for ACDF patients.

Study Design

Study Type:
Interventional
Actual Enrollment :
11 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Intervention Model Description:
Patients enrolled in the study & scheduled for surgical intervention with anterior cervical discectomy and fusion will have the superficial sensor applied to the suprasternal notch following closure of the surgical incision. The data collected by the sensor will be recorded via a remote application and the sensor will then be removed 24 hours following placement. All patients enrolled in the study will be affixed with an identical sensor in accordance with the procedure outlined in the study protocol.Patients enrolled in the study & scheduled for surgical intervention with anterior cervical discectomy and fusion will have the superficial sensor applied to the suprasternal notch following closure of the surgical incision. The data collected by the sensor will be recorded via a remote application and the sensor will then be removed 24 hours following placement. All patients enrolled in the study will be affixed with an identical sensor in accordance with the procedure outlined in the study protocol.
Masking:
None (Open Label)
Primary Purpose:
Other
Official Title:
Feasibility Assessment of A Novel Wearable Skin Sensor for Post-Operative Monitoring Following Anterior Cervical Discectomy and Fusion (ACDF)
Actual Study Start Date :
Mar 15, 2021
Actual Primary Completion Date :
Jan 6, 2022
Anticipated Study Completion Date :
Aug 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Wearable Sensor Applied

For these participants, the wearable ADAM sensor will be placed in the sternal notch to record anatomical data during the post-surgical period for up to 14 days

Procedure: Anterior Cervical Discectomy & Fusion
Participants are undergoing previously scheduled anterior cervical discectomy & fusion for single level or multiple level cervical disease

Device: Application of ADAM mechanoacoustic skin sensor
Applying the ADAM sensor to the suprasternal notch following surgery to allow for collection of the anatomical data

Outcome Measures

Primary Outcome Measures

  1. Vibrational Frequency of Vocalization Following Surgery [0 to 24 hours post operative]

    Sensitivity of the device to mechanoacoustic output from motion and vocalization in hertz (Hz)

  2. Skin Temperature of the Surgical Site [0 to 24 hours post operative]

    Sensitivity of the device to temperature of the surgical site in degrees Celsius

  3. Muscular Force Generated During Range of Motion Exercises [0 to 24 hours post operative]

    Force vectors measured in gravitational acceleration units (g; 9.81 meters per second squared)

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 88 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients who have undergone anterior cervical discectomy and fusion (ACDF) for one or more levels for a diagnosis of cervical radiculopathy or myelopathy

  • Scheduled to return to the MSK orthopaedic clinic for a post-operative appointment

  • Aged between 18 to 88 years at time of surgery

Exclusion Criteria:
  • Patients that underwent a revision of previous ACDF surgery at one or more operative levels

  • Surgeries performed for a traumatic or oncologic etiology

  • Members of vulnerable populations (i.e. prisoners, pregnant women)

Contacts and Locations

Locations

Site City State Country Postal Code
1 Northwestern Memorial Hospital Chicago Illinois United States 60611

Sponsors and Collaborators

  • Northwestern University

Investigators

  • Principal Investigator: Alpesh A Patel, BSE, MD, MBA, Northwestern University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Alpesh A. Patel, Professor of Orthopaedic Surgery, Professor of Neurological Surgery, Northwestern University
ClinicalTrials.gov Identifier:
NCT04921800
Other Study ID Numbers:
  • STU00213413
First Posted:
Jun 10, 2021
Last Update Posted:
Jul 5, 2022
Last Verified:
Jul 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
Yes
Product Manufactured in and Exported from the U.S.:
No
Keywords provided by Alpesh A. Patel, Professor of Orthopaedic Surgery, Professor of Neurological Surgery, Northwestern University

Study Results

No Results Posted as of Jul 5, 2022